Announced Mon, 27 Jul · 18:05 IST
Q1 FY27 results: Revenue up 144% YoY, losses narrow
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹52.74
prior close
₹52.74
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—-4.2————————————
Up moveDown movePending
AI summary
Oxygenta Pharma posted Q1 FY27 revenue of Rs 3,699.69 lakhs, up 144% from Rs 1,513.47 lakhs a year ago. Net loss narrowed sharply to Rs 210.37 lakhs from Rs 610.61 lakhs YoY. Loss before tax was Rs 250.73 lakhs vs Rs 814.80 lakhs. Finance costs rose nearly 4x to Rs 245.50 lakhs. Availed Rs 399 lakhs ECLGS loan. Cost auditor appointed; AGM set for Aug 21.
Likely market impact
Strong revenue growth and shrinking losses are positive, but company is still loss-making and took emergency credit loan.